Doctolib valuation, funding and investors
Doctolib works in healthcare software suite development, based in Levallois-Perret, France. Founded in 2024, it has about 2 employees.
VALUATION · TODAY
$7.04B +0% after Growth
Range $638M – $8.10B · Grade DTODAY
+12 MO
$2.00B
$4.00B
$6.00B
$8.00B
$10.00B
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series B $20.0M
Growth $170M
Growth $550M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY3 employees
+0%6m growth
+50%1y growth
+0%2y growth
2
4
Data from Jan 2021
Predicted in 1 yr $7.04B +0% vs today
Predicted next raise $691M if a round comes
Winding-down probability 0%
- Last round
- Growth · $550M · Mar 2022
- Valuation at last round
- $6.40B
- Headcount
- 3
- Grade
- D
- Founded
- 2024
Doctolib valuation today
VCMC values Doctolib at $7.0B today, with a range of $638M to $8.1B and a grade of D. The valuation starts from its last funding round, a growth round in Mar 2022.
Valuation by date (146 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2015 | $3.23M | $1.18M – $8.88M | $3.39M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2015 | $3.25M | $1.18M – $8.92M | $3.40M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2015 | $3.26M | $1.19M – $8.95M | $3.41M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2015 | $3.27M | $1.19M – $8.99M | $3.43M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2015 | $3.28M | $1.20M – $9.02M | $3.44M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2015 | $3.30M | $1.20M – $9.06M | $3.45M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2015 | $3.31M | $1.20M – $9.09M | $3.47M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2015 | $3.32M | $1.21M – $9.13M | $3.56M (+7%) | before first round | – | unknown | D | 0% |
| 1 Sep 2015 | $3.34M | $1.21M – $9.16M | $3.65M (+10%) | before first round | – | unknown | D | 0% |
| 1 Oct 2015 | $3.35M | $1.22M – $9.20M | $3.75M (+12%) | before first round | – | unknown | D | 0% |
| 15 Oct 2015 | $131M | $86.1M – $299M | $197M (+50%) | after a round | – | unknown | C | 0% |
| 1 Nov 2015 | $134M | $86.1M – $299M | $197M (+47%) | after a round | – | unknown | C | 0% |
| 1 Dec 2015 | $138M | $86.1M – $299M | $197M (+42%) | after a round | – | unknown | C | 0% |
| 1 Jan 2016 | $143M | $86.1M – $299M | $197M (+37%) | after a round | – | unknown | C | 0% |
| 1 Feb 2016 | $148M | $86.1M – $299M | $197M (+33%) | after a round | – | unknown | C | 0% |
| 1 Mar 2016 | $153M | $86.1M – $299M | $197M (+29%) | after a round | – | unknown | C | 0% |
| 1 Apr 2016 | $158M | $86.1M – $299M | $197M (+24%) | after a round | – | unknown | C | 0% |
| 1 May 2016 | $164M | $86.1M – $299M | $197M (+20%) | after a round | – | unknown | C | 0% |
| 1 Jun 2016 | $169M | $86.1M – $299M | $197M (+16%) | after a round | – | unknown | C | 0% |
| 1 Jul 2016 | $175M | $86.1M – $299M | $197M (+12%) | after a round | – | unknown | C | 0% |
| 1 Aug 2016 | $181M | $86.1M – $299M | $197M (+8%) | after a round | – | unknown | C | 0% |
| 1 Sep 2016 | $188M | $86.1M – $299M | $197M (+5%) | after a round | – | unknown | C | 0% |
| 1 Oct 2016 | $194M | $86.1M – $299M | $197M (+1%) | after a round | – | unknown | C | 0% |
| 1 Nov 2016 | $197M | $83.8M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2016 | $197M | $80.3M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2017 | $197M | $76.9M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2017 | $197M | $73.5M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2017 | $197M | $70.7M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2017 | $197M | $67.6M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $197M | $64.8M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $197M | $62.0M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $197M | $59.4M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $197M | $56.8M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $197M | $54.4M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $197M | $52.1M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $197M | $45.8M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $197M | $43.6M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $197M | $41.5M – $299M | $197M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $197M | $39.4M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2018 | $197M | $37.6M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2018 | $197M | $35.8M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2018 | $197M | $34.1M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2018 | $197M | $32.4M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Jul 2018 | $197M | $30.8M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Aug 2018 | $197M | $29.3M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2018 | $197M | $27.8M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2018 | $197M | $26.5M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2018 | $197M | $25.2M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2018 | $197M | $24.0M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2019 | $197M | $22.8M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2019 | $197M | $21.6M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2019 | $197M | $20.7M – $299M | $197M (0%) | after a round | – | unknown | D | 0% |
| 21 Mar 2019 | $1.1B | $987M – $1.4B | $1.2B (+10%) | after a round | – | unknown | A | 0% |
| 1 Apr 2019 | $1.1B | $987M – $1.4B | $1.2B (+10%) | after a round | – | unknown | A | 0% |
| 1 May 2019 | $1.1B | $987M – $1.4B | $1.2B (+9%) | after a round | – | unknown | A | 0% |
| 1 Jun 2019 | $1.2B | $987M – $1.4B | $1.2B (+8%) | after a round | – | unknown | A | 0% |
| 1 Jul 2019 | $1.2B | $987M – $1.4B | $1.2B (+7%) | after a round | – | unknown | A | 0% |
| 1 Aug 2019 | $1.2B | $987M – $1.4B | $1.2B (+6%) | after a round | – | unknown | A | 0% |
| 1 Sep 2019 | $1.2B | $987M – $1.4B | $1.2B (+5%) | after a round | – | unknown | A | 0% |
| 1 Oct 2019 | $1.2B | $987M – $1.4B | $1.2B (+5%) | after a round | – | unknown | A | 0% |
| 1 Nov 2019 | $1.2B | $987M – $1.4B | $1.2B (+4%) | after a round | – | unknown | A | 0% |
| 1 Dec 2019 | $1.2B | $987M – $1.4B | $1.2B (+3%) | after a round | – | unknown | A | 0% |
| 1 Jan 2020 | $1.2B | $987M – $1.4B | $1.2B (+2%) | after a round | – | unknown | A | 0% |
| 1 Feb 2020 | $1.2B | $987M – $1.4B | $1.2B (+1%) | after a round | – | unknown | A | 0% |
| 1 Mar 2020 | $1.2B | $987M – $1.4B | $1.2B (0%) | after a round | – | unknown | A | 0% |
| 1 Apr 2020 | $1.2B | $966M – $1.4B | $1.2B (0%) | after a round | – | unknown | A | 0% |
| 1 May 2020 | $1.2B | $920M – $1.4B | $1.2B (0%) | after a round | – | unknown | A | 0% |
| 1 Jun 2020 | $1.2B | $874M – $1.4B | $1.2B (0%) | after a round | – | unknown | A | 0% |
| 1 Jul 2020 | $1.2B | $832M – $1.4B | $1.2B (0%) | after a round | – | unknown | A | 0% |
| 1 Aug 2020 | $1.2B | $791M – $1.4B | $1.2B (0%) | after a round | – | unknown | A | 0% |
| 1 Sep 2020 | $1.2B | $752M – $1.4B | $1.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Oct 2020 | $1.2B | $715M – $1.4B | $1.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Nov 2020 | $1.2B | $680M – $1.4B | $1.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Dec 2020 | $1.2B | $647M – $1.4B | $1.2B (0%) | after a round | – | unknown | B | 0% |
| 1 Jan 2021 | $1.2B | $615M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 Feb 2021 | $1.2B | $585M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 Mar 2021 | $1.2B | $558M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 Apr 2021 | $1.2B | $531M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 May 2021 | $1.2B | $505M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 Jun 2021 | $1.2B | $480M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 Jul 2021 | $1.2B | $457M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 Aug 2021 | $1.2B | $434M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | B | 0% |
| 1 Sep 2021 | $1.2B | $413M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | C | 0% |
| 1 Oct 2021 | $1.2B | $393M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | C | 0% |
| 1 Nov 2021 | $1.2B | $373M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | C | 0% |
| 1 Dec 2021 | $1.2B | $355M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | C | 0% |
| 1 Jan 2022 | $1.2B | $338M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | C | 0% |
| 1 Feb 2022 | $1.2B | $321M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | C | 0% |
| 1 Mar 2022 | $1.2B | $306M – $1.4B | $1.2B (0%) | after a round | 1 | unknown | C | 0% |
| 16 Mar 2022 | $6.4B | $5.6B – $8.1B | $7.0B (+10%) | after a round | 1 | unknown | A | 0% |
| 1 Apr 2022 | $6.4B | $5.6B – $8.1B | $7.0B (+10%) | after a round | 3 | unknown | A | 0% |
| 1 May 2022 | $6.5B | $5.6B – $8.1B | $7.0B (+9%) | after a round | 3 | unknown | A | 0% |
| 1 Jun 2022 | $6.5B | $5.6B – $8.1B | $7.0B (+8%) | after a round | 3 | unknown | A | 0% |
| 1 Jul 2022 | $6.6B | $5.6B – $8.1B | $7.0B (+7%) | after a round | 3 | unknown | A | 0% |
| 1 Aug 2022 | $6.6B | $5.6B – $8.1B | $7.0B (+6%) | after a round | 3 | unknown | A | 0% |
| 1 Sep 2022 | $6.7B | $5.6B – $8.1B | $7.0B (+5%) | after a round | 3 | unknown | A | 0% |
| 1 Oct 2022 | $6.7B | $5.6B – $8.1B | $7.0B (+4%) | after a round | 3 | unknown | A | 0% |
| 1 Nov 2022 | $6.8B | $5.6B – $8.1B | $7.0B (+4%) | after a round | 3 | unknown | A | 0% |
| 1 Dec 2022 | $6.9B | $5.6B – $8.1B | $7.0B (+3%) | after a round | 3 | unknown | A | 0% |
| 1 Jan 2023 | $6.9B | $5.6B – $8.1B | $7.0B (+2%) | after a round | 3 | unknown | A | 0% |
| 1 Feb 2023 | $7.0B | $5.6B – $8.1B | $7.0B (+1%) | after a round | 3 | unknown | A | 0% |
| 1 Mar 2023 | $7.0B | $5.6B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | A | 0% |
| 1 Apr 2023 | $7.0B | $5.4B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | A | 0% |
| 1 May 2023 | $7.0B | $5.2B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | A | 0% |
| 1 Jun 2023 | $7.0B | $4.9B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | A | 0% |
| 1 Jul 2023 | $7.0B | $4.7B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | A | 0% |
| 1 Aug 2023 | $7.0B | $4.4B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Sep 2023 | $7.0B | $4.2B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Oct 2023 | $7.0B | $4.0B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Nov 2023 | $7.0B | $3.8B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Dec 2023 | $7.0B | $3.6B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Jan 2024 | $7.0B | $3.4B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Feb 2024 | $7.0B | $3.3B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Mar 2024 | $7.0B | $3.1B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Apr 2024 | $7.0B | $3.0B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 May 2024 | $7.0B | $2.8B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Jun 2024 | $7.0B | $2.7B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Jul 2024 | $7.0B | $2.6B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | B | 0% |
| 1 Aug 2024 | $7.0B | $2.4B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Sep 2024 | $7.0B | $2.3B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Oct 2024 | $7.0B | $2.2B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Nov 2024 | $7.0B | $2.1B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Dec 2024 | $7.0B | $2.0B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Jan 2025 | $7.0B | $1.9B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Feb 2025 | $7.0B | $1.8B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Mar 2025 | $7.0B | $1.7B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Apr 2025 | $7.0B | $1.6B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 May 2025 | $7.0B | $1.6B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Jun 2025 | $7.0B | $1.5B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Jul 2025 | $7.0B | $1.4B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Aug 2025 | $7.0B | $1.3B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Sep 2025 | $7.0B | $1.3B – $8.1B | $7.0B (0%) | after a round | 3 | unknown | C | 0% |
| 1 Oct 2025 | $6.4B | $1.1B – $7.4B | $6.4B (0%) | after a round | 2 | unknown | C | 0% |
| 1 Nov 2025 | $5.5B | $900M – $6.4B | $5.5B (0%) | after a round | 1 | unknown | C | 0% |
| 1 Dec 2025 | $5.5B | $857M – $6.4B | $5.5B (0%) | after a round | 1 | unknown | D | 0% |
| 1 Jan 2026 | $5.5B | $814M – $6.4B | $5.5B (0%) | after a round | 1 | unknown | D | 0% |
| 1 Feb 2026 | $5.5B | $774M – $6.4B | $5.5B (0%) | after a round | 1 | unknown | D | 0% |
| 1 Mar 2026 | $7.0B | $941M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 1 Apr 2026 | $7.0B | $894M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 1 May 2026 | $7.0B | $851M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 1 Jun 2026 | $7.0B | $809M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 1 Jul 2026 | $7.0B | $770M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 1 Aug 2026 | $7.0B | $732M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 1 Sep 2026 | $7.0B | $696M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 1 Oct 2026 | $7.0B | $662M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
| 24 Oct 2026 | $7.0B | $638M – $8.1B | $7.0B (0%) | after a round | 3 | unknown | D | 0% |
Key facts about Doctolib
- Founded
- 2024
- Headquarters
- Levallois-Perret, France
- Employees
- about 2
- Total raised
- $740M
- Funding rounds
- 3
- Last round
- Growth Equity Mar 2022
Doctolib funding history
Doctolib has 3 funding rounds on record, from Oct 2015 to Mar 2022, $740M in total. The latest disclosed valuation is $6.40B post-money (Growth Equity, Mar 2022).
Growth Equity 15 Mar 2022
Led by Eurazeo; with Bpifrance, General Atlantic.
Sources: trainy.co, techcrunch.com, frenchhealthcare.com and 1 more
$550M
$6.40B post-money
Growth Equity 20 Mar 2019
Led by General Atlantic; with Accel, Bpifrance, Eurazeo, Kernel Capital.
Sources: finsmes.com, generalatlantic.com, techcrunch.com and 3 more
$170M
$1.13B post-money
$20M
Doctolib investors
5 investors have backed Doctolib; Accel, Eurazeo and General Atlantic led at least one round.
- Accel lead, 2 rounds
- Eurazeo lead, 2 rounds
- General Atlantic lead, 2 rounds
- Bpifrance 2 rounds
What Doctolib does
Doctolib works in tech companies, with 11 recorded offerings and customers in healthcare.
Doctolib is a French company engaged in providing software solutions for healthcare professionals, including doctors, nurses, and other providers, with a focus on automating clinical and administrative tasks. The company also operates a teleconsultation platform that enables patients to book appointments online and supports teleconsultation processes with AI-assisted tools. Doctolib serves healthcare professionals and patients across France, Germany, Italy, and the Netherlands, and is committed to data security, privacy, sustainability, and accessibility in its operations.
Description from Veridion's company data.
Products and services
- Healthcare Software Suite Development
- AI-Powered Teleconsultation Platform Development
- Clinical Activity Management Software Development
- Administrative Activity Management Software Development
- Patient Appointment Booking Platform Development
- Teleconsultation Assistant Development
- Secure Medical Document Sharing Platform Development
- Mobile Healthcare Application Development
- AI in Healthcare Research and Development
- Healthcare Technology Accessibility Consulting
- Healthcare Technology Sustainability Consulting
Markets
- Healthcare
Technology
- AI-Powered Teleconsultation Assistant
- AI-Driven Patient Care Personalization
- AI-Enabled Preventive Care Recommendations
- AI-Driven Document Sharing for Healthcare
Business model
- Business-to-Business
- Business-to-Consumer
- Software-as-a-Service
Industry codes (NAICS)
- 513210 Software Publishers 100% match
Questions about Doctolib
What is Doctolib worth?
Valuation $7.0B (range $638M to $8.1B), as of 24 Oct 2026. The last disclosed valuation was $6.40B (Growth Equity, Mar 2022).
Has Doctolib raised money?
Doctolib has 3 funding rounds on record, from Oct 2015 to Mar 2022, $740M in total. The latest disclosed valuation is $6.40B post-money (Growth Equity, Mar 2022).
Who has invested in Doctolib?
Accel, Eurazeo, General Atlantic, Bpifrance and Kernel Capital. Lead investors include Accel, Eurazeo and General Atlantic.
How many people work at Doctolib?
About 2. Headcount grew from 1 in Jan 2021 to 3 in Jun 2026.
What does Doctolib do?
Doctolib works in tech companies, with 11 recorded offerings and customers in healthcare. Its main offerings are healthcare software suite development, AI-Powered teleconsultation platform development and clinical activity management software development.
When was Doctolib founded, and where is it based?
Doctolib was founded in 2024 and is based in Levallois-Perret, France. It has about 2 employees.